Geneoscopy

Geneoscopy

Biotechnology Research

St. Louis, MO 6,272 followers

Cancer Prevention | Diagnostics | Precision Medicine

About us

Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense™ test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
St. Louis, MO
Type
Privately Held
Founded
2015
Specialties
Life Sciences, Noninvasive Diagnostic Screening, Colorectal Cancer Screening, GI Health, GI Disease Companion Diagnostics, seRNA, RNA Biomarkers, Precision Medicine Partnerships, and IBD

Locations

Employees at Geneoscopy

Updates

Similar pages

Browse jobs

Funding